Common theme of hope resonates at inaugural CHOC/UCI Rare Disease Symposium and Family Conference
CHOC/UCI's first-ever Rare Disease Symposium and Family Conference garnered the attention of over 300 participants. CHOC and UCI experts presented virtually, offering hope to the rare disease community that there is ground-breaking rare disease research and treatments to come. Read more.
CHOC accepted as member of prestigious fetal program oversight body
The Fetal Care Center of Southern California, a partnership between CHOC and UCI, is the first fetal program in the region to be approved for membership for the North American Fetal Therapy Network. This network presents the opportunity to share knowledge and facilitate access to treatments for complex fetal disorders. Learn more.
Formula substitutions for families
With the formula shortage causing anxiety for many parents, CHOC experts offer a list of formula substitutions that providers can share with their patients and families. Get substitutions.
Breakthrough research from Australia could lead to the prevention of sudden infant death syndrome (SIDS)
Researchers at The Children’s Hospital at Westmead in Sydney, Australia have identified the first biochemical marker that could help detect babies more at risk of SIDS while they are alive. Read more.
7 stress relief strategies for providers
CHOC’s mental health team offers many useful resources to the community. One of which is a set of videos explaining techniques such as deep breathing, journaling and giving thanks to relieve stress. Not only are these strategies helpful for families, but providers too. Get strategies.
How 4 hospital CEOs view their legacies
Four hospital CEOs, including CHOC President and CEO Kimberly Chavalas Cripe, share how they approach their personal legacies and the legacies of the organizations they lead — and how the changing climate of healthcare has impacted these legacies. Hear from Kim.
How COVID-19 vaccines are helping to pave the way for a vaccine for HIV
The urgency to create a COVID-19 vaccine has proven the safety and efficacy of mRNA vaccines, which may help advance the development of an mRNA vaccine for HIV. This is exciting news for scientists who have been working on an HIV vaccine for the last four decades, and who now hope that it will be available in the next five or six years. Learn more.